Andy Reddick has been director of Acura since August 2004 and President and Chief Executive Officer since August 2003. From April 2000 to September 2002 Mr. Reddick was Chief Operating Officer and Sr. Vice President of Commercial Operations for Adolor Corporation. Adolor is a specialty pharmaceutical company focused on opioid receptor technology and related product development and commercialization. From June 1999 to March 2000 Mr. Reddick was President of Faulding Laboratories Inc. a specialty pharmaceutical division focused on commercializing branded opioid analgesics and related products. From August 1996 to June 1999 he was Executive Vice President Marketing Sales and Business Development with Purepac Pharmaceuticals a major developer manufacturer and distributor of generic pharmaceuticals including a broad range of controlled substances. In addition Mr. Reddick served for more than 20 years on the management team and in senior level roles at Burroughs Wellcome Co. an international pharmaceutical company based in the United Kingdom.

Mr. Reddick holds a Bachelor of Arts degree in Biology from the University of California and a Master of Business Administration from Duke University.